Abstract:Purpose: In this prospective study, we aimed to test the feasibility of dynamic Gd-EOB-DTPA-enhanced MRI with a free-breathing T1 mapping technique in a single scan and examine the influence of functional future liver remnant(FLR) on the incidence of post-hepatectomy liver failure(PHLF) in patients who underwent major liver resection for suspected bile duct cancer(BTC) after bile drainage. Method: Patients were included for suspected biliary tract tumor with a plan for hepatectomy in this prospective study between 2020 and 2022. Patients were excluded if artifacts existed on images or with a history of radiotherapy or chemotherapy before surgery. PHLF was defined and graded according to the International Study Group of Liver Surgery(ISGLS) criterion. All the scans were performed on a 3.0 T MR scanner (Philips Healthcare) and functional liver indexes were calculated accordingly. GOAL-SNAP sequence was optimized for quantifying T1 of the liver including an inversion recovery (IR) preparation pulse followed by a series of 3D golden angle radial acquisition. Results: Total 49 patients met the inclusion criteria and completed preoperative routine MRI sequence, among whom 33 patients completed additional free-breathing T1 mapping sequence. Perihilar cholangiocarcinoma was the main clinical diagnosis on admission in 46 patients. The other diagnoses were carcinoma of common bile duct and gallbladder carcinoma(n=3). △T1, △T1%, HEF(n=33) and UR(n=32) of the whole liver have statistical significance correlations with preoperative liver biochemical indexes and ICG test(Fig. 1). In this study, 39 patients finally underwent major liver resection and thus were included for PHLF analysis. According to ISGLS criterion, 16 patients happened PHLF which 10 patients were diagnosed in grade B and C.There were no difference between PHLF and NO PHLF groups in surgical characteristics. Univariable and multivariable analysises for PHLF were shown in Table 1(Results with P<0.05). Conclusion: In this prospective study, the correlation results have demonstrated MRI parameters' clinical feasibility for liver function estimation in patients with BTC. The proposed functional liver volume rate (45%) could be considered as an important factor influencing PHLF in BTC patients, and therefore it provides functional reference for selection of patients underwent hepatectomy instead of using CT-based volumetric calculation when MRI is available.Tabled 1Table 1VariablesUnivariable analysisMultivariable analysisOR (95% CI)pOR (95% CI)pPT, sec2.52(1.29-4.93)0.0072.57(1.21-5.42)0.01APTT, sec1.51(1.12-2.03)0.0071.72(1.16-2.53)0.007sFLRRE10, %0.01(0.00-0.68)0.030.004(0.00-0.47)0.02sFLRRE15, %0.003(0.00-0.37)0.020.002(0.00-0.43)0.02sFLRRE15<45%6.12(1.42-26.36)0.026.50(1.17-36.05)0.03sFLRRE20, %0.003(0.00-0.31)0.020.001(0.00-0.37)0.02sFLRRE20<45%5.67(1.37-23.46)0.026.11(1.13-33.09)0.03FLRHEF, ml0.99(0.97-0.99)0.030.98(0.97-0.99)0.04 Open table in a new tab

Four indices on Gd-EOB-DTPA-enhanced MRI can estimate liver functional reserve compared to ICG-R15: A systematic review and meta-analysis.

Application Values of Gadolinium-ethoxybenzyl Diethylenetriaminepentaacetic Acid Enhanced Magnetic Resonance Imaging-based Radiomics in the Quantitative Assessment of Liver Reserve Function of Patients with Liver Cirrhosis

The Clinical Significance of Indocyanine Green Excretion Test in Evaluation of Liver Functional Reserve

Evaluation of Liver Function Reserve with Gadoxetate Disodium-Enhanced MR

Quantitative assessment of liver function with hepatocyte fraction: Comparison with T1 relaxation‐based indices

Hepatic Function Imaging Using Dynamic Gd-EOB-DTPA Enhanced MRI and Pharmacokinetic Modeling

Regional Liver Function Assessment Using Free-breathing T1 Mapping in Gadoxetic Acid–enhanced MRI for Patients with Bile Duct Cancer: A Prospective Study

Assessing Liver Function in Liver Tumors Patients: the Performance of T1 Mapping and Residual Liver Volume on Gd-EOBDTPA-Enhanced MRI

Assessing Liver Function by T1 Maps on Gd-EOB-DTPA-Enhanced MRI for up to 50 Min in Rat Models of Liver Fibrosis: A Longer Hepatobiliary Time Period may Help

Progresses of functional imaging in assessment of liver function reserve

Gadoxetate-disodium-enhanced Magnetic Resonance Imaging for Liver Fibrosis Staging: a Systematic Review and Meta-Analysis

Utility of gadoxetate disodium-enhanced magnetic resonance imaging in evaluating liver failure risk after major hepatic resection

Gd-BOPTA enhanced MRI in evaluation of reserved liver function

Preliminary study of hepatocyte-specific MR contrast agent in the evaluation of liver function

Assessing liver function by liver enhancement during the hepatobiliary phase with Gd-EOB-DTPA-enhanced MRI at 3 Tesla

Hepatobiliary magnetic resonance imaging in patients with liver disease: correlation of liver enhancement with biochemical liver function tests

Assessment of Liver Fibrosis Using Pharmacokinetic Parameters of Dynamic Contrast-Enhanced Magnetic Resonance Imaging.

Clinical Laboratory Parameters Predicting the Insufficient Liver Enhancement on the Hepatocyte-Phase of Gd-EOB-DTPA-Enhanced Magnetic Resonance Imaging

Is Gadoxetic Acid Disodium (Gd-EOB-DTPA)-Enhanced Magnetic Resonance Imaging an Accurate Diagnostic Method for Hepatocellular Carcinoma? A Systematic Review with Meta-Analysis

Combined morphological and functional liver MRI using spin-lattice relaxation in the rotating frame (T1ρ) in conjunction with Gadoxetic Acid-enhanced MRI

Deep Learning-Based Assessment of Functional Liver Capacity Using Gadoxetic Acid-Enhanced Hepatobiliary Phase MRI